Disease Area

cervical neoplasms

Cervical Neoplasms is an active area of clinical research and therapeutic development covered by The Life Science Feed. Our editorial team tracks the latest clinical trials, treatment guidelines, regulatory updates, and scientific advances relevant to Cervical Neoplasms. Browse the latest articles below for in-depth analysis and evidence-based clinical insights.

Cervical Neoplasms
Adding Pembrolizumab to Chemotherapy Extends Survival in Advanced Cervical Cancer
A Phase 3 trial demonstrates that adding pembrolizumab to standard chemotherapy, with or without bevacizumab, significantly improves progression-free and overall survival for patients with persistent, recurrent, or metastatic cervical cancer.
Get the full story
4 min read
Cervical Neoplasms
Cervical Cancer Elimination: Why Income Isn't the Only Barrier
A new model suggests structural factors beyond income, such as health system capacity and education, are critical for cervical cancer elimination. Comprehensive policy engagement is needed to meet WHO targets globally.
Get the full story
3 min read
Cervical Neoplasms
Pembrolizumab Improves Overall Survival in Locally Advanced Cervical Cancer
Adding pembrolizumab to chemoradiotherapy significantly improved overall survival in patients with high-risk, locally advanced cervical cancer. This combination therapy reduced the risk of death by 33% compared to placebo.
Get the full story
4 min read

Loading articles...